WASHINGTON, DC 20549

                                   FORM 12b-25

                           NOTIFICATION OF LATE FILING

                         Commission File Number 0-28498

(Check one)

|X| Form 10-K and Form 10-KSB   |_| Form 11-K

|_| Form 20-F  |_| Form 10-Q and Form 10-QSB  |_| Form N-SAR

For period ended: December 31, 2006

|_| Transition Report on Form 10-K and Form 10-KSB

|_| Transition Report on Form 20-F

|_| Transition Report on Form 11-K

|_| Transition Report on Form 10-Q and Form 10-QSB

|_| Transition Report on Form N-SAR

For the transition period ended _____________________________________________

Read Attached Instruction Sheet Before Preparing Form.  Please Print or Type.

   Nothing in this form shall be  construed  to imply  that the  Commission  has
verified any information contained herein.

   If the  notification  relates  to a  portion  of the  filing  checked  above,
identify the item(s) to which the notification relates


                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant: Paradigm Medical Industries, Inc.

Former name if applicable: ____________________________________________________

Address of principal executive office (Street and number):

                        2355 South 1070 West
                        Salt Lake City, Utah 84119

                                     PART II
                             RULE 12b-25(b) AND (c)

   If the  subject  report  could not be filed  without  unreasonable  effort or
expense  and the  registrant  seeks  relief  pursuant  to Rule  132b-25(b),  the
following should be completed. (Check box if appropriate).

            (a)         The reasons  described in reasonable  detail in Part III
                        of  this   form   could   not  be   eliminated   without
                        unreasonable effort or expense.

   |X|      (b)         The   subject   annual   report,   semi-annual   report,
                        transition  report on Form 10-K, Form 20-F, 11-K or Form
                        N-SAR,  or portion  thereof,  will be filed on or before
                        the fifteenth  calendar day following the prescribed due
                        date;  or the  subject  quarterly  report of  transition
                        report on Form 10-Q, or portion thereof will be filed on
                        or  before  the  fifth   calendar  day   following   the
                        prescribed due date; and

            (c)         The accountant's  statement or other exhibit required by
                        Rule 12(b)-25(c) has been attached if applicable.

                                    PART III

   State below in  reasonable  detail the reasons  why Forms 10-K,  11-K,  10-Q,
N-SAR or the transition report or portion thereof, could not be filed within the
prescribed time period. (Attach extra sheets if needed.)

   The Form 10-KSB cannot be completed  within the prescribed time period due to
the additional time required because of the complexities  involved in completing
the required financial statements.

                                     PART IV
                                OTHER INFORMATION

(1)  Name  and  telephone  number  of  person  to  contact  in  regard  to  this

             Randall A. Mackey          (801)             575-5000
             -----------------       -----------     ------------------
                  (name)             (area code)     (telephone number)

(2) Have all other  periodic  reports  required under Section 13 or 15(d) of the
Securities  Exchange Act of 1934 or Section 30 of the Investment  Company Act of
1940  during the  preceding  12 months  (or for such  shorter)  period  that the
registrant  was  required to file such  report(s)  been filed?  If answer is no,
identify report(s).

            |X|Yes    |_| No

(3) Is it anticipated that any significant  change in results of operations from
the  corresponding  period for the last  fiscal  year will be  reflected  by the
earnings statements to be included in the subject report or portion thereof?

If so, attach an explanation of the  anticipated  change,  both  narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.

            |_| Yes    |X| No

                        Paradigm Medical Industries, Inc.
                  (Name of Registrant as Specified in Charter)

Has  caused  this  notification  to be signed on its  behalf by the  undersigned
hereunto duly authorized.

Date:  April 3, 2007                    By: /s/ Raymond P.L. Cannefax
                                           Raymond P.L. Cannefax
                                           President and Chief Executive Officer